Browse Category

Earnings Reports News 28 January 2026

Carvana stock sinks nearly 20% after Gotham short-seller report; Wall Street eyes earnings next

Carvana stock sinks nearly 20% after Gotham short-seller report; Wall Street eyes earnings next

New York, January 28, 2026, 14:23 (EST) — Regular session Shares of Carvana Co plunged roughly 19.5% to $384.57 Wednesday afternoon after short seller Gotham City Research released a report accusing the company of accounting irregularities and undisclosed related-party deals. The stock had closed Tuesday at $477.72 and fluctuated between $375.13 and $482.31 during the session. Carvana did not immediately respond to requests for comment. (Investing.com) This hit matters since Carvana has been one of the market’s most polarizing turnaround stories, with investors divided over the durability of its profits and the reliance on credit markets. A short report targeting
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

New York, Jan 28, 2026, 14:13 EST — Regular session Elevance Health Inc (NYSE: ELV) shares climbed roughly 6% Wednesday, recovering sharply in afternoon trading. The insurer established a profit floor for 2026 despite forecasting a slight drop in revenue. The stock jumped $20.22 to $343.14, with intraday moves ranging from $293.01 to $347.45. Investors are scrambling to reassess the managed-care sector following a Medicare Advantage shakeup this week. On Monday, the Centers for Medicare & Medicaid Services proposed a net average payment rise of just 0.09% for 2027. They also unveiled tweaks to the risk-adjustment model, which increases payouts
KLA (KLAC) stock price slips as traders brace for earnings after ASML’s AI-order surge

KLA (KLAC) stock price slips as traders brace for earnings after ASML’s AI-order surge

New York, Jan 28, 2026, 13:27 EST — Regular session KLA Corp shares dipped 0.1% to $1,614.56 midday Wednesday, after fluctuating between $1,602.27 and $1,690.00 earlier in the session. The nervous trading matters since investors want a clear signal on chip-equipment demand, and KLA’s results often set the tone for the sector. It’s among the rare stocks seen as a direct gauge of how aggressively fabs are boosting yields on cutting-edge chips. KLA sells inspection and measurement tools — “process control” equipment that helps chipmakers identify defects and boost yield, meaning the share of usable chips produced from a wafer.
Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

New York, January 28, 2026, 13:10 EST — Regular session. Avnet, Inc. shares surged roughly 11% Wednesday following a quarterly earnings report that beat estimates and a third-quarter forecast that exceeded expectations. By 1:01 p.m. EST, the stock had climbed 11.3% to $58.65, reaching an intraday peak of $58.84 earlier. This move is crucial as investors seek clear signals on demand and pricing within the global electronics supply chain, where distributors often risk carrying excess inventory if customers halt orders. Avnet serves as a key indicator for this segment of tech hardware. Positioned between chipmakers and end customers, shifts in
Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

New York, January 28, 2026, 13:02 EST — Trading in regular session. Pfizer shares dropped 1.8% to $26.02 in early afternoon trading, having fluctuated between $25.97 and $26.39. The pullback arrives as investors absorb a fresh U.S. Medicare drug-pricing list featuring Pfizer’s arthritis drug Xeljanz. For major pharmaceutical companies, the inclusion signals that Washington’s price cuts have shifted from headline risk to a ticking clock on the calendar. This round is crucial because it directly impacts 2026 planning: companies will negotiate in 2026, but the prices set then won’t take effect until 2028. It also broadens the scope beyond just
Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

New York, Jan 28, 2026, 12:53 PM EST — Regular session ongoing. Shares of Mastercard Inc slipped slightly on Wednesday, losing roughly 0.1% to hit $519.71. Earlier in the session, the stock fluctuated between $518.24 and $523.11. The drift happens just ahead of the payments company’s Q4 and full-year results, followed by an earnings call at 9 a.m. ET on Thursday. U.S. investors are on edge about consumer spending trends heading into 2026. (investor.mastercard.com) Mastercard jumped into the AI race before earnings season ramps up. On Tuesday, it unveiled “Mastercard Agent Suite,” a bundle of tools to help companies roll
RTX stock slips after earnings: what to watch next on dividends, tariffs, Pratt recall

RTX stock slips after earnings: what to watch next on dividends, tariffs, Pratt recall

New York, Jan 28, 2026, 12:54 (EST) — Regular session RTX Corp shares slipped Wednesday, retreating after a post-earnings lift as investors digested the defense and aerospace giant’s 2026 forecast amid changing policy winds in Washington. The stock fell 0.4% to $200.47 by midday. Why it matters now: RTX is caught between ramping up its defense output quickly and managing a commercial aerospace sector that’s still tangled in supply chain issues and an expensive jet-engine inspection program. Shareholders are focused not only on how much RTX can sell but also on how it chooses to deploy its cash. The White
Visa stock price ticks up on Redburn upgrade as earnings day nears

Visa stock price ticks up on Redburn upgrade as earnings day nears

New York, Jan 28, 2026, 12:49 EST — Regular session Shares of Visa Inc (V) ticked up 0.2% to $325.90 on Wednesday following Rothschild Redburn’s upgrade of the payments giant to “Buy,” with a price target boost from $327 to $385. The stock fluctuated between $324.52 and $328.36 during the session. (Investing.com) Visa’s fiscal first-quarter results are due after the U.S. market closes on Thursday, with a webcast set for 5:00 p.m. Eastern. The company noted it is currently in a standard “quiet period,” so executives won’t engage with investors until the numbers are released. (Visa Investor Relations) Timing is
Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move

Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move

New York, Jan 28, 2026, 11:37 EST — Regular session Lam Research shares slipped 0.1% to $238.15 by 11:37 a.m. EST, retreating from an early gain and edging toward session lows ahead of the chip equipment maker’s quarterly report scheduled after the bell. The setup is straightforward but tense. Chip-tool makers are benefiting from a surge in AI-driven spending, yet their fate hinges on customer guidance about factory plans over the coming quarters. Options traders are pricing in a big move. According to TipRanks, implied volatility suggests Lam’s stock could swing roughly 7.9% up or down after the earnings report,
Amphenol stock price slides 11% after record results; investors wait on CCS details

Amphenol stock price slides 11% after record results; investors wait on CCS details

New York, Jan 28, 2026, 11:34 EST — Regular session Amphenol Corp shares dropped roughly 11% to $147.69 in morning trading, swinging between a low of $140.10 and a high of $173.49. The stock slid $18.56 from its previous close, with about 16.4 million shares changing hands. The drop surprises given Amphenol’s reputation as a go-to for investors targeting wiring and connectors in data centers, defense equipment, and industrial electronics. When a stock falls hard despite strong headline growth, it usually signals the market is scrutinizing the details — separating organic gains from acquisitions and questioning what’s sustainable. Amphenol reported
GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

New York, January 28, 2026, 11:28 EST — Regular session GE Vernova shares ticked up 0.4% to $695.58 in late-morning trading Wednesday following an upgraded 2026 forecast from the power-equipment firm. Still, a new caution from its wind division kept the stock volatile. Earlier, the price swung between $659.34 and $742.24. The report is crucial now as investors pile into everything tied to the power buildout — turbines, transformers, switchgear — while utilities and major buyers hunt for capacity. GE Vernova stands at the heart of that supply chain, its years-long order books offering a glimpse into just how strained
Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

New York, Jan 28, 2026, 11:23 (ET) — Regular session Shares of Banco Bradesco S.A. listed in the U.S. edged up Wednesday, staying near a 52-week high. Investors held back ahead of Brazil’s interest-rate announcement scheduled for later and digested a flurry of company updates ahead of next week’s earnings. (Investing.com) This matters now because of rates. Brazilian banks often react to the Selic, the country’s key benchmark rate, since it influences loan demand, funding costs, and credit stress on household balance sheets. This week’s focus centers on inflation figures and the central bank’s Copom policy committee kicking off its
1 65 66 67 68 69 334

Stock Market Today

AppLovin stock price rebounds 8% as tech steadies, Feb. 11 earnings loom

AppLovin stock price rebounds 8% as tech steadies, Feb. 11 earnings loom

7 February 2026
AppLovin shares jumped 8.3% to $406.72 Friday, trading over 6.5 million shares after a volatile session. The move followed a broader AI-driven tech rebound that lifted software stocks. Investors now await AppLovin’s Feb. 11 earnings and outlook for signals on ad demand and future growth.
CoreWeave stock price jumps 20% as CRWV rebounds on ARENA launch, earnings date looms

CoreWeave stock price jumps 20% as CRWV rebounds on ARENA launch, earnings date looms

7 February 2026
CoreWeave shares surged 20% to $89.95 in after-hours trading Friday after the company launched its ARENA platform for testing AI workloads at scale. Volume exceeded 36 million shares. The move follows a rough week for the stock and comes ahead of CoreWeave’s earnings report on Feb. 26. A regulatory filing showed Chief Development Officer Brannin McBee sold shares on Feb. 2 under a prearranged plan.
Go toTop